| CAS | Product Name | MF |
|
1234858-94-6
|
(1R,5S,6S)-rel-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Methyl Ester
|
C13H20O4
|
|
251326-99-5
|
(1R-4S)-4-[[(1,1-dimethylethoxy)carbonyl]amino]- 2-Cyclopentene-1-carboxylic acid methyl ester
|
C12H19NO4
|
|
16695-41-3
|
trans-7-dodecenylacetate
|
C14H26O2
|
|
89929-27-1
|
9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one
|
C17H23NO3
|
|
2247481-21-4
|
JSH 150
|
C24H33ClN6O2S
|
|
74893-46-2
|
Sodium 2-fluoroacrylate
|
C3H2FNaO2
|
|
1798304-51-4
|
(4-cyclopropyl-6-methoxypyrimidin-5-yl)boronic acid(WX192149)
|
C8H11BN2O3
|
|
5776-78-3
|
HEXANOICACID,6-[[6-[(6-AMINO-1-OXOHEXYL)AMINO]-1-OXOHEXYL]AMINO]-
|
C18H35N3O4
|
|
1022158-35-5
|
4-BroMo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
|
C12H13BrN2O
|
|
2937-54-4
|
2-AMINOETHANETHIOSULFONIC S-ACID
|
C2H7NO2S2
|
|
956139-21-2
|
(6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate
|
C37H37ClN5O5P
|
|
101038-78-2
|
(CYS0)-ADENYLATE CYCLASE-STIMULATING G-ALPHA PROTEIN (28-42)
|
C85H144N30O24S
|
|
83048-35-5
|
quercetin 3-sambubioside
|
C26H28O16
|
|
169506-15-4
|
2-(2-Ethoxyphenoxy)ethyl Methanesulfonate
|
C11H16O5S
|
|
99584-96-0
|
2,5-dibroMohexanediaMide
|
C6H10Br2N2O2
|
|
508241-14-3
|
Pyrazino[2,1-c][1,4]oxazine, octahydro-, (9aR)- (9CI)
|
C7H14N2O
|
|
632-50-8
|
1,1,2,2-TETRAPHENYLETHANE
|
C26H22
|
|
1340593-59-0
|
VT-1161
|
C23H16F7N5O2
|
|
143655-58-7
|
N-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydro-1-naphthyl)acetamide
|
C13H14FNO2
|
|
5465-20-3
|
5-hexylbenzene-1,3-diol
|
C12H18O2
|
|
1256794-12-3
|
Methyl 3-amino-6-(trifluoromethyl)pyridine-2-carboxylate
|
C8H7F3N2O2
|
|
516-50-7
|
2-[4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid
|
C26H45NO6S
|
|
186393-31-7
|
trans-3,4-Dihydroxypyrrolidine
|
C4H9NO2
|
|
1126779-11-0
|
3,5-Dimethyl-1-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol95%
|
C16H27BN2O3
|
|
26402-79-9
|
PHENOXY RESIN
|
C54H60O9X2
|
|
1359704-84-9
|
tert-butyl 2-oxo-6-azaspiro[3.5]nonane-6-carboxylate
|
C13H21NO3
|
|
349536-39-6
|
6'-DesMethyl-6'-carboxy Etoricoxib
|
C18H13ClN2O4S
|
|
1626-00-2
|
PHENYLTRIMETHYLGERMANE
|
C9H14Ge
|
|
5858-81-1
|
LITHOL RUBIN BCA
|
C18H15N2NaO6S
|
|
1242157-15-8
|
6-Bromo-8-fluoro-3,4-dihydroisoquinolin-1(2H)-one
|
C9H7BrFNO
|
|
875910-01-3
|
AGA-(C8R) HNG17, Humanin derivative
|
C78H134N20O24
|
|
54364-62-4
|
(7Z,9E)-dodeca-7,9-dienyl acetate
|
C14H24O2
|
|
149715-47-9
|
(R)-2-HYDROXYMETHYL-PIPERAZINE-2HCl
|
C5H12N2O
|
|
994-07-0
|
chlorodimethoxymethylsilane
|
C3H9ClO2Si
|
|
152708-24-2
|
Valsartan Impurity 32
|
C14H11N7
|
|
110652-62-5
|
PEPTIDE M
|
C81H141N21O31
|
|
41670-62-6
|
1,2-distearoylmonoglactosylglyceride
|
C45H86O10
|
|
1483-97-2
|
3,6-Diacetyl-9-ethyl-9H-carbazole
|
C18H17NO2
|
|
851233-24-4
|
(4-(Bis(4-(tert-butyl)phenyl)amino)phenyl)boronic acid
|
C26H32BNO2
|
|
6504-13-8
|
4-(1H-BENZOIMIDAZOL-2-YL)-PHENOL
|
C13H10N2O
|
|
4840-69-1
|
5-fluoro-3-methyl-1H-pyrimidine-2,4-dione
|
C5H5FN2O2
|
|
1256822-80-6
|
3-Bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine
|
C6H3BrFN3
|
|
204254-94-4
|
(3R,4R,5R)-4-(1-Ethylpropoxy)-3-hydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester
|
C15H26O7S
|
|
96850-13-4
|
INDATRALINE HYDROCHLORIDE
|
C16H16Cl3N
|
|
1335-30-4
|
Silicic acid, aluminum salt
|
Al2O9Si3
|
|
1771765-84-4
|
(R)-3-(4-(6-(1H-tetrazol-5-yl)pyridin-3-yl)-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one
|
C16H13FN6O3
|
|
196597-27-0
|
(R)-Ramelteon
|
C16H21NO2
|
|
1171919-08-6
|
Ethyl 4-(trifluoromethyl)-2-pyridinecarboxylate
|
C9H8F3NO2
|
|
628692-21-7
|
2-Fluoro-4-Methoxyphenylboronic acid pinacol ester
|
C13H18BFO3
|
|
777899-57-7
|
2-Chloro-5-nitro-isonicotinic acid methyl ester
|
C7H5ClN2O4
|
|
1353644-70-8
|
(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide
|
C25H26N6O2
|
|
2245111-15-1
|
3-Pyridazinecarboxylic acid, 4,6-dichloro-, lithium salt, hydrate (1:1:1)
|
C5H5Cl2LiN2O3
|
|
127955-44-6
|
Erythromycin EP Impurity L
|
C37H65NO14
|
|
447-44-9
|
4-FLUORO-6-(1H)INDAZOLE CARBOXYLIC ACID
|
C8H5FN2O2
|
|
25053-53-6
|
POLY(ETHYLENE-CO-METHACRYLIC ACID)
|
C6H10O2
|
|
827616-51-3
|
3-Pyridinecarboxylic acid, 4-cyano-
|
C7H4N2O2
|
|
108825-05-4
|
Clemastine
|
C21H26ClNO2
|
|
154006-66-3
|
(S)-AMINO-(3-FLUORO-PHENYL)-ACETIC ACID
|
C8H8FNO2
|
|
229615-05-8
|
(1S,2S,3R,4R)-Methyl 3-((R)-1-acetaMido-2-ethylbutyl)-4-aMino-2-hydroxycyclopentanecarboxylate
|
C15H28N2O4
|
|
2375564-55-7
|
ACBI1
|
C49H58FN9O7S
|
|
5052-95-9
|
1-Oxa-3,8-diazaspiro(4.5)decan 2-one
|
C7H12N2O2
|
|
14221-00-2
|
TETRAKIS(TRIPHENYL PHOSPHITE)NICKEL(0)
|
C72H60NiO12P4
|
|
68955-19-1
|
Sulfuric acid, mono-C12-18-alkyl esters, sodium salts
|
C15H31NaO4S
|
|
129306-04-3
|
5-Azaspiro[2.4]heptane-4,7-dione, 5-(phenylMethyl)-
|
C13H13NO2
|
|
51744-66-2
|
5,6-trans-Ergocalciferol
|
C28H44O
|
|
141256-04-4
|
QS 21
|
C92H148O46
|
|
332398-57-9
|
4-Carboxynaphthalene-1-boronic acid
|
C11H9BO4
|
|
3338-24-7
|
sodium O,O-diethyl dithiophosphate
|
C4H10NaO2PS2
|
|
100342-53-8
|
RebaMipide iMpurity 1
|
C18H15ClN2O2
|
|
439082-09-4
|
1,2-Benzisoxazole, 6-fluoro-3-(1,2,3,6-tetrahydro-4-pyridinyl)-
|
C12H11FN2O
|
|
169044-96-6
|
2-Amino-5-bromo-4-methoxy-benzoic acid methyl ester
|
C9H10BrNO3
|
|
610273-01-3
|
C-JUN PEPTIDE
|
C121H210N36O34S
|
|
22411-22-9
|
HAFNIUM N-BUTOXIDE
|
C16H36HfO4
|
|
2229864-78-0
|
1-(3-Bromophenyl)dibenzofuran
|
C18H11BrO
|
|
2648641-36-3
|
TPX-0131
|
C21H20F3N5O3
|
|
23208-66-4
|
Cyanocobalamin Impurity F
|
C63H85CoN13O15P
|
|
2732926-24-6
|
N-Desethyl Isotonitazene
|
C21H26N4O3
|
|
1257554-02-1
|
3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-imidazo[4,5-b]pyridine
|
C13H18BN3O2
|
|
1026438-56-1
|
TelMisartan IMpurity B
|
C37H38N4O2
|
|
204254-90-0
|
(3aR,7R,7aR)-2,2-Diethyl-3a,6,7,7a-tetrahydro-7-[(Methylsulfonyl)oxy]-1,3-benzodioxole-5-carboxylic Acid Ethyl Ester
|
C15H24O7S
|
|
1421640-34-7
|
Methyl Pyridine Sulfonate
|
C6H7NO3S
|
|
51630-33-2
|
VALERATE
|
C24H23ClO3
|
|
96567-93-0
|
1-BENZYL-3-METHYLPYRROLIDIN-3-OL
|
C12H17NO
|
|
53902-93-5
|
3-bromopyrazolo[1,5-a]pyrazine
|
C6H4BrN3
|
|
1643378-48-6
|
Ticagrelor Impurity 15
|
C23H28F2N6O4S
|
|
34948-62-4
|
2-amino-2-deoxy-beta-D-galactopyranose 1,3,4,6-tetraacetate hydrochloride
|
C14H22ClNO9
|
|
303191-26-6
|
Pentafluorophenylpropyltrimethoxysilane
|
C12H15F5O3Si
|
|
733043-41-9
|
3-HYDROXYANAGRELIDE
|
C10H7Cl2N3O2
|
|
10242-09-8
|
5-METHYL-BENZOFURAN-2-CARBOXYLIC ACID
|
C10H8O3
|
|
907193-65-1
|
(2β)-Methyl Megestrol Acetate
|
C25H34O4
|
|
3380-30-1
|
HYDROXYDICHLORODIPHENYL ETHER
|
C12H8Cl2O2
|
|
61950-59-2
|
(D-TRP8,D-CYS14)-SOMATOSTATIN-14
|
C76H104N18O19S2
|
|
1391041-75-0
|
triphenyl[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]silane
|
C30H31BO2Si
|
|
293733-21-8
|
2-AMINO-6-ETHOXYNAPHTHALENE
|
C12H13NO
|
|
206055-79-0
|
N6-Bz-2'-O-4'-A-Locked-Ar-CE-Phosphoramidite
|
C48H52N7O8P
|
|
1791405-13-4
|
Linagliptin Impurity C
|
C15H20N6O2
|
|
885-94-9
|
Ethyl 1-phenyl-1H-pyrazole-4-carboxylate, 97%
|
C12H12N2O2
|
|
1515866-60-0
|
7-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine
|
C13H19BN2O3
|
|
1616340-94-3
|
(2R,5S,13aR)-8-methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
C22H20F3N3O5
|
|
13985-15-4
|
9,10-diMethyl-2,3,6,7-tetraMethoxy-anthracene
|
C20H22O4
|